T Konno
- Topics
- Cancer, Hypoxia, and Metabolism (9 papers)Hepatocellular Carcinoma Treatment and Prognosis (8 papers)Cancer, Lipids, and Metabolism (6 papers)
- Partner nations
- JapanUnited Kingdom
In The Last Decade
T Konno
17 papers receiving 418 citations
Peers
Comparison fields: 5 of 59
- Hepatology 275
- Epidemiology 105
- Cancer Research 83
- Molecular Biology 69
- Pulmonary and Respiratory Medicine 65
Countries citing papers authored by T Konno
This map shows the geographic impact of T Konno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T Konno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T Konno more than expected).
Fields of papers citing papers by T Konno
This network shows the impact of papers produced by T Konno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T Konno. The network helps show where T Konno may publish in the future.
Co-authorship network of co-authors of T Konno
This figure shows the co-authorship network connecting the top 25 collaborators of T Konno. A scholar is included among the top collaborators of T Konno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T Konno. T Konno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | 16 | |
| 3 | Targeted vinblastine chemotherapy with two preparations of lipiodol contrast medium. | 2 |
| 4 | 25 | |
| 5 | [Targeted chemotherapy of hepatocellular carcinoma with SMANCS/Lipiodol--how to use SMANCS/Lipiodol]. | 2 |
| 6 | 60 | |
| 7 | [Antitumor activities of oily suspended zinostatin stimalamer (YM 881) against VX2 carcinoma implanted in the liver of rabbits--comparison with another anticancer agent]. | 1 |
| 8 | 13 | |
| 9 | [A case of massive hepatoma which responded to SMANCS/Lipiodol regimen with intra-arterial infusion]. | 1 |
| 10 | [Antitumor activities of oily suspended YM881 (SMANCS) against VX2 carcinoma]. | 1 |
| 11 | [Significance of lipiodol-CT in the evaluation of therapeutic effects of Lp-TAE for hepatocellular carcinoma--clinicopathologic study]. | 2 |
| 12 | [Targeting cancer chemotherapy using lipiodol as a carrier of anticancer drugs for hepatocellular carcinoma]. | 1 |
| 13 | [Targeting chemotherapy of hepatocellular carcinoma by arterial administration of anticancer agents dissolved in lipiodol]. | 2 |
| 14 | Tumor targeting by arterial administration of lipids: rabbit model with VX2 carcinoma in the liver. | 35 |
| 15 | [CT image of the liver cancer after administration of SMANCS/lipiodol]. | 1 |
| 16 | 249 | |
| 17 | A clinical trial of live attenuated varicella vaccine (Biken) in children with malignant diseases. | 8 |
About T Konno
T Konno is a scholar working on Hepatology, Cancer Research and Biochemistry, having authored 17 papers that have together received 427 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (9 papers), Hepatocellular Carcinoma Treatment and Prognosis (8 papers) and Cancer, Lipids, and Metabolism (6 papers). The work is most often cited by research in Hepatology (275 citations), Cancer Research (83 citations) and Biomaterials (56 citations). T Konno has collaborated with scholars based in Japan and United Kingdom. Frequent co-authors include Hajime Maeda, Y Yumoto, Yoshihiro Araki, Kenji Jinno, S Iwamoto, K Okuda, K Ohnishi, K. Yamasaki, Yuya Miyauchi and Y Matsumura. Their work appears in journals such as Radiology, European Journal of Cancer and Experimental Biology and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.